Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apixaban”

274 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 274 results

Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Large-scale testing (Phase 3)Study completedNCT03181386
What this trial is testing

Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants

Who this might be right for
Atrial FibrillationPeriodontal DiseaseHemorrhage
University of Sao Paulo General Hospital 60
Not applicableStudy completedNCT03254147
What this trial is testing

Medical Need of OAC Reversal

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 53,969
Testing effectiveness (Phase 2)Ended earlyNCT02749617
What this trial is testing

A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma

Who this might be right for
Anti-Xa Activity
University of British Columbia 2
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Post-approval studies (Phase 4)Study completedNCT02295475
What this trial is testing

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeThrombosis
Scott C. Woller, MD 48
Not applicableStudy completedNCT03515083
What this trial is testing

Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm

Who this might be right for
Non-valvular Atrial Fibrillation
Saint Luke's Health System 100
Not applicableStudy completedNCT02640222
What this trial is testing

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 321,501
Post-approval studies (Phase 4)Study completedNCT02090075
What this trial is testing

Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque

Who this might be right for
Atrial Fibrillation
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 66
Testing effectiveness (Phase 2)Ended earlyNCT04106700
What this trial is testing

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Who this might be right for
Venous Thromboembolism
Instituto de Investigacion Sanitaria La Fe 60
Not applicableStudy completedNCT05471505
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 120,722
Not applicableStudy completedNCT04141228
What this trial is testing

Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US

Who this might be right for
Venous Thromboembolism (VTE)
Bristol-Myers Squibb 28,000
Testing effectiveness (Phase 2)Study completedNCT00313300
What this trial is testing

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome (ACS)
Bristol-Myers Squibb 1,741
Large-scale testing (Phase 3)Looking for participantsNCT06742567
What this trial is testing

Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction of Anterior WallLeft Ventricular ThrombusProphylaxis
National Institute of Cardiovascular Diseases, Pakistan 472
Large-scale testing (Phase 3)Looking for participantsNCT05198960
What this trial is testing

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+2 more
University Hospital, Brest 1,308
Large-scale testing (Phase 3)Study completedNCT05208398
What this trial is testing

Apixaban in Patients With Left Ventricular Thrombus

Who this might be right for
Left Ventricular Thrombus
Saud Al Babtain Cardiac Center 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT05687448
What this trial is testing

DIrect Oral Anticoagulation and Bioprothesis Aortic Valve

Who this might be right for
Aortic Valve Disease
Assistance Publique - Hôpitaux de Paris 1,500
Post-approval studies (Phase 4)Not Yet RecruitingNCT06953726
What this trial is testing

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

Who this might be right for
Atrial Fibrillation
VA Office of Research and Development 10,000
Large-scale testing (Phase 3)Study completedNCT00633893
What this trial is testing

Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Who this might be right for
Venous Thrombosis
Bristol-Myers Squibb 2,711
Post-approval studies (Phase 4)Study completedNCT05632445
What this trial is testing

Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)

Who this might be right for
Left Atrial Appendage Occlusion
DR. XAVIER FREIXA 160
Load More Results